Last updated on February 2018

Diagnostic Value of KL-6 in ILD


Brief description of study

KL-6 may be a useful biomarker in patients with interstitial lung disease, but there is limited information in non-Asian populations. Therefore, it is necessary to carry out studies in other populations to confirm the diagnostic values of the biomarker and its prognostic implication.

Hypothesis KL-6 may be a useful biomarker in the management of interstitial lung diseases. But it is necessary to know more about its utility in the European population.

Study Objectives:

  • To determine the concentration of KL-6 in serum of patients with pulmonary fibrosis at the time of diagnosis compared to patients without pulmonary fibrosis
  • Diagnostic yield of KL-6 in patients with pulmonary fibrosis.
  • Correlation of KL-6 values with functional and radiological parameters of disease severity at diagnosis.
  • Correlation of serum KL-6 values with the evolution of the disease.

Clinical Study Identifier: NCT03103191

Find a site near you

Start Over

Recruitment Status: Open


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.